A team at Nashville, Tenn.-based Vanderbilt Heart and Vascular Institute successfully employed a robotic device to place a patient’s central line.
Vanderbilt Health is one of five centers selected by the FDA to study the Obvius Robotics device for central line placement, according to a March 18 news release.
Led by Aniket Rali, MD, co-director of the medical cardiovascular ICU, the team first used the device in January on a patient receiving a pulmonary artery pressure monitoring device.
“It basically does the job of what may take a human experience over 100 cases to perform with that level of precision and safety,” Dr. Rali said in the news release. “It makes the entire process of getting the needle into the blood vessel much more precise.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
